Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Alternative Donor Hematopoietic Cell Transplantation for Pediatric, Adolescent and Young Adult with Hematological Diseases

Nicole Karras, MD, Ni-Chun Tsai, MS, Ahmed Tahoun, MD, Saloomeh Mokhtari, Haris Ali, MD, Shukaib Arslan, MD, Anna B Pawlowska, MD, Chatchada Karanes, Joseph Rosenthal, MD MS, David S Snyder, MD, Stephen J. Forman, MD, Ryotaro Nakamura, MD, Monzr M. Al Malki, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141334

Published: 2020

Journal Articles

Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139993

Published: 2020

Journal Articles

Efficacy of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Peripheral Blood Stem Cell HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation; A Prospective Pilot Trial

Monzr M. Al Malki, MD, Ni-Chun Tsai, MS, Joycelynne Palmer, PhD, Saloomeh Mokhtari, Thai Cao, MD, Haris Ali, MD, Amandeep Salhotra, MD, Shukaib Arslan, MD, Ibrahim Aldoss, MD, Nicole Karras, MD, Haris M. Ali, MD, Haris Ali, MD, Anthony S. Stein, MD, David S Snyder, MD, Guido Marcucci, MD, Stephen J. Forman, MD, Ryotaro Nakamura, MD

Blood (2020) 136 (Supplement 1): 49–50.

https://doi.org/10.1182/blood-2020-142807

Published: 2020

Journal Articles

Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administration in Combination with Reduced Intensity Conditioning

Haris Ali, MD, David Snyder, MD, Tracy Stiller, MS, Timothy Synold, PhD, Saloomeh Mokhtari, Joycelynne Palmer, PhD, Amandeep Salhotra, MD, Vinod A. Pullarkat, MD, Ji-lian Cai, MD, Stephen J Forman, MD, Matthew Mei, MD, Ryotaro Nakamura, MD

Blood (2019) 134 (Supplement_1): 669.

https://doi.org/10.1182/blood-2019-127445

Published: 2019

Journal Articles

Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplantation: Outcome Data Analysis

Janny M. Yao, PharmD, Dongyun Yang, PhD, Saloomeh Mokhtari, Amandeep Salhotra, MD, Haris Ali, MD, Shukaib Arslan, MD, Salman Otoukesh, MD, Ibrahim Aldoss, MD, Karamjeet S. Sandhu, MD, Anthony Stein, MD, David Snyder, MD, Vinod A. Pullarkat, MD, Guido Marcucci, MD, Stephen J Forman, MD, Ryotaro Nakamura, MD, Monzr M. Al Malki, MD

Blood (2019) 134 (Supplement_1): 4518.

https://doi.org/10.1182/blood-2019-129221

Published: 2019

Journal Articles

MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis

Blood (2018) 132 (Supplement 1): 1752.

https://doi.org/10.1182/blood-2018-99-112239

Published: 2018

Journal Articles

A Human Bone Marrow-Derived Stromal Cell Population with Hemogenic Potential

Saloomeh Mokhtari, Evan Joseph Colletti, PhD, Chad Sanada, PhD, Zanetta S. Lamar, MD, Paul J Simmons, Anthony Atala, MD, Diane S Krause, MD PhD, Esmail D. Zanjani, PhD, Christopher D Porada, PhD, Graca Almeida-Porada, MD PhD

Blood (2015) 126 (23): 1201.

https://doi.org/10.1182/blood.V126.23.1201.1201

Published: 2015

Journal Articles

Defining Engraftment Patterns and Interactions Between Hematopoietic Stem Cells and Stromal Cells after in Utero Transplantation

Saloomeh Mokhtari, Christopher D Porada, PhD, Evan Joseph Colletti, PhD, Graca Almeida-Porada, MD PhD

Blood (2015) 126 (23): 1869.

https://doi.org/10.1182/blood.V126.23.1869.1869

Published: 2015

Journal Articles

A New Approach to Expand Cord Blood Derived Hematopoietic Stem Cells, Using Bioengineered Human Fetal Liver Tissue 3D-Constructs

Saloomeh Mokhtari, Pedro Baptista, Dipen Vyas, PhD, Charles Jordan Freeman, Emma Moran, PhD, Christopher D Porada, PhD, Shay Soker, PhD, Graca Almeida-Porada, MD PhD

Blood (2015) 126 (23): 3097.

https://doi.org/10.1182/blood.V126.23.3097.3097

Published: 2015

Journal Articles

CD166+CD34+ Cells Exhibit Marked Functional Differences During Fetal and Adult Life

Saloomeh Mokhtari, Zanetta S. Lamar, MD, Chris Booth, Frank Marini, III, PhD, Christopher D Porada, PhD, Graca Almeida-Porada, MD, PhD

Blood (2013) 122 (21): 2435.

https://doi.org/10.1182/blood.V122.21.2435.2435

Published: 2013

Journal Articles

Optimization Of Vascular Niches To Increase Hematopoietic Engraftment

Saloomeh Mokhtari, Evan Colletti, PhD, Christopher D Porada, PhD, Graca Almeida-Porada, MD, PhD

Blood (2013) 122 (21): 4456.

https://doi.org/10.1182/blood.V122.21.4456.4456

Published: 2013

Journal Articles

Origin and Characterization of CD166+ Cells During Human Marrow Ontogeny

Saloomeh Mokhtari, BS, Evan Colletti, PhD, Christopher D Porada, PhD, Graca Almeida-Porada, MD, PhD

Blood (2012) 120 (21): 1252.

https://doi.org/10.1182/blood.V120.21.1252.1252

Published: 2012

Journal Articles

Identification and Phenotypic Characterization of a Subpopulation of Acute Myelogenous Leukemia (AML) Cells with Increased Plastic Adherence.

Katharine Greenfield, BS, Saloomeh Mokhtari, BS, Melissa Haug, Christopher D Porada, PhD, Graca Almeida-Porada, MD, PhD

Blood (2012) 120 (21): 2556.

https://doi.org/10.1182/blood.V120.21.2556.2556

Published: 2012

Journal Articles

Timing of Mesenchymal Stem Cell Co-Transplantation and Site of Bone Engraftment Determine Levels of Hematopoietic Engraftment and Contribution of HSC to the Bone Niche

Evan Colletti, Saloomeh Mokhtari, Chad Sanada, Esmail D Zanjani, Christopher D Porada, PhD, Graca Almeida-Porada, MD, PhD

Blood (2010) 116 (21): 940.

https://doi.org/10.1182/blood.V116.21.940.940

Published: 2010

NARROW

Alternative Donor Hematopoietic Cell Transplantation for Pediatric, Adolescent and Young Adult with Hematological Diseases

Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis

Efficacy of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Peripheral Blood Stem Cell HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation; A Prospective Pilot Trial

Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administration in Combination with Reduced Intensity Conditioning

Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplantation: Outcome Data Analysis

MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis

A Human Bone Marrow-Derived Stromal Cell Population with Hemogenic Potential

Defining Engraftment Patterns and Interactions Between Hematopoietic Stem Cells and Stromal Cells after in Utero Transplantation

A New Approach to Expand Cord Blood Derived Hematopoietic Stem Cells, Using Bioengineered Human Fetal Liver Tissue 3D-Constructs

CD166+CD34+ Cells Exhibit Marked Functional Differences During Fetal and Adult Life

Optimization Of Vascular Niches To Increase Hematopoietic Engraftment

Origin and Characterization of CD166+ Cells During Human Marrow Ontogeny

Identification and Phenotypic Characterization of a Subpopulation of Acute Myelogenous Leukemia (AML) Cells with Increased Plastic Adherence.

Timing of Mesenchymal Stem Cell Co-Transplantation and Site of Bone Engraftment Determine Levels of Hematopoietic Engraftment and Contribution of HSC to the Bone Niche

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only